Enfusion, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 3 | $0.04 | $0.04 | $0.04 |
| Q2 2024 | 2 | $0.06 | $0.06 | $0.06 |
| Q3 2024 | 7 | $0.04 | $0.07 | $0.06 |
| Q4 2024 | 2 | $0.07 | $0.07 | $0.07 |
| Q1 2025 | 3 | $0.07 | $0.07 | $0.07 |
| Q2 2025 | 3 | $0.07 | $0.07 | $0.07 |
| Q3 2025 | 6 | $0.08 | $0.08 | $0.08 |
| Q4 2025 | 5 | $0.09 | $0.09 | $0.09 |
| Q1 2026 | 4 | $0.08 | $0.08 | $0.08 |
| Q2 2026 | 3 | $0.08 | $0.08 | $0.08 |
| Q3 2026 | 2 | $0.09 | $0.09 | $0.09 |
| Q4 2026 | 2 | $0.11 | $0.11 | $0.11 |
Enfusion, Inc. Earnings Date And Information
Enfusion, Inc. last posted its earnings results on Tuesday, August 6th, 2024. The company reported $0.05 earnings per share for the quarter, missing analysts' consensus estimates of $0.06 by $0.01. The company had revenue of 49.46 M for the quarter and had revenue of 174.54 M for the year. Enfusion, Inc. has generated $0 earnings per share over the last year ($0.0466 diluted earnings per share) and currently has a price-to-earnings ratio of 222.18. Enfusion, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 4th, 2024 based on prior year's report dates.
Enfusion, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/06/2024 | Q2 2024 | $0.06 | $0.02 | -0.04 | $49.97 M | $49.46 M |
| 05/09/2024 | Q1 2024 | $0.04 | -$0.01 | -0.04 | $48.05 M | |
| 03/12/2024 | Q4 2023 | $0.06 | $0.01 | -0.05 | $46.49 M | |
| 11/07/2023 | Q3 2023 | $0.05 | $0.02 | -0.03 | $43.90 M | $44.36 M |
| 08/08/2023 | Q2 2023 | $0.05 | $0.01 | -0.04 | $44.59 M | $42.72 M |
| 05/09/2023 | Q1 2023 | $0.04 | $0.05 | 0.01 | $40.97 M | |
| 03/10/2023 | Q4 2022 | $0.01 | $40.52 M | |||
| 11/10/2022 | Q3 2022 | $0.01 | $0.02 | 0.01 | $38.64 M | $39.15 M |
| 08/10/2022 | Q2 2022 | -$0.03 | $35.58 M | $36.54 M | ||
| 05/13/2022 | Q1 2022 | -$0.16 | $34.14 M | |||
| 03/30/2022 | Q4 2021 | -$3.53 | $31.85 M | |||
| 12/03/2021 | Q3 2021 | $0.05 | $29.05 M | |||
| 06/29/2021 | Q2 2021 | $0.07 | $26.45 M | |||
| 03/30/2021 | Q1 2021 | $0.06 | $24.35 M | |||
| 12/30/2020 | Q4 2020 | -$0.19 | $22.66 M | |||
| 09/29/2020 | Q3 2020 | $0.09 | $19.79 M | |||
| 06/29/2020 | Q2 2020 | $0.08 | $18.56 M | |||
| 03/30/2020 | Q1 2020 | $0.06 | $18.56 M |
Enfusion, Inc. Earnings: Frequently Asked Questions
-
When is Enfusion, Inc.'s earnings date?
Enfusion, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 4th, 2024 based off last year's report dates.
-
How can I listen to Enfusion, Inc.'s earnings conference call?
The conference call for Enfusion, Inc.'s latest earnings report can be listened to online.
-
How can I read Enfusion, Inc.'s conference call transcript?
The conference call transcript for Enfusion, Inc.'s latest earnings report can be read online.
-
How much revenue does Enfusion, Inc. generate each year?
Enfusion, Inc. (:ENFN) has a recorded annual revenue of $174.54 M.
-
How much profit does Enfusion, Inc. generate each year?
Enfusion, Inc. (:ENFN) has a recorded net income of $174.54 M. Enfusion, Inc. has generated $0.0683 earnings per share over the last four quarters.
-
What is Enfusion, Inc.'s price-to-earnings ratio?
Enfusion, Inc. (:ENFN) has a price-to-earnings ratio of 222.18 and price/earnings-to-growth ratio is 5.07.
